Patents
US Patent 11,969,401 for MaculaPM™
COMPOSITIONS AND METHODS FOR TREATING OR LIMITING DEVELOPMENT OF AGE-RELATED MACULAR DEGENERATION
US Patent 9,861,600 for MaculaPM™
METHODS AND COMPOSITIONS FOR TREATING AND IDENTIFYING COMPOUNDS TO TREAT AGE-RELATED MACULAR DEGENERATION TREATMENT
US Patent 9,173,862 for MaculaPM™
METHODS AND COMPOSITIONS FOR TREATING AND IDENTIFYING COMPOUNDS TO TREAT AGE-RELATED MACULAR DEGENERATION
Additional Patents Licensed for Use
(a) United States Patent Number U.S. 11,969,401 entitled •compositions and Methods for Treating or Limiting Development of Age-Related Macular Degeneration· issued on April 30, 2024 {ARIZONA Ref No. UA19-094); and (b) United States Patent Number U.S. 9,173,862 entitled “Methods and Compositions for Treating and Identifying Compounds to Treat Age-Related Macular Degeneration” issued on November 3,…